FTHM vs NBIX · rev $201.0M vs P/E 45, rev $1.77B
Fathom Holdings Inc (FTHM) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Fathom Holdings Inc (FTHM) is a real estate services company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported FTHM revenue for 2026-06-30 was $201.0M. Net income was -$14.4M. FTHM currently screens at market cap $36.9M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
FTHM currently screens at market cap $36.9M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the FTHM and NBIX stock pages for the full models.
Not investment advice.